Bioadaptives, Inc. SEC filings BDPT
Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 4, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 22, 2024 | May 20, 2024 |
| 8-K |
Current report
Auditor change
|
May 14, 2024 | May 13, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 6, 2023 | Apr 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 3, 2022 | Feb 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 21, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 27, 2021 | Aug 26, 2021 |
| 8-K |
Current report
Other events
|
Jul 22, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jun 11, 2021 | May 31, 2021 |
| 8-K |
Current report
Other events
|
Jun 16, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Other events
|
May 11, 2020 | May 11, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 11, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 27, 2019 | Sep 11, 2019 |
| 8-K |
Current report
Auditor change
|
Apr 23, 2015 | Apr 23, 2015 |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2015 | Feb 6, 2015 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 15, 2014 | Jul 13, 2014 |
| 8-K |
Current report
Other events
|
Jul 10, 2014 | Jul 8, 2014 |
| 8-K |
Current report
Material agreement, Auditor change
|
May 23, 2014 | May 20, 2014 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control
|
Oct 25, 2013 | Oct 21, 2013 |
| 8-K |
Current report
Unregistered share sale
|
Oct 8, 2013 | Oct 1, 2013 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 30, 2013 | Sep 24, 2013 |
| 8-K/A |
Amended current report
Change in control, Officer or director change
|
Aug 6, 2013 | Jun 21, 2013 |
| 8-K |
Current report
Change in control, Officer or director change
|
Jul 5, 2013 | Jun 21, 2013 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDPT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1575142
- Former names
- APEX 8 Inc. (until Aug 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.